Fairvalue-Calculator Fairvalue-Calculator
EN DE

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co (301130) Fair Value & Analysis

Healthcare · CN · Market cap 2.0B CNY

Price¥25.43
Fair Value¥5.27
Upside-79.3%
Quality91/100
Evidence: Medium Range ¥4.40 – ¥6.15

Fair value as of: Jun 24, 2026

Analysis

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co (301130) currently trades at ¥25.43, while our model-based Fair Value estimate is ¥5.27 — implying the stock looks roughly 79.3% overvalued today. We read business quality at 91/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd engages in the research and development, production, and sales of chemical raw materials and pharmaceutical preparations in China. The company provides drugs for the treatment of anemia, mental disorders, anti-psychotic disorders, cardiovascular and cerebrovascular diseases, and tumors. It provides drugs in the form of tablets and capsules. The company was founded in 1990 and is headquartered in Panshi, China.

Open the full interactive analysis →

Similar stocks

Takeda Pharmaceutical Company (TAKP34) +3193% Jiangsu Hengrui Pharmaceuticals Co (600276) -37% Sun Pharmaceutical Industries Limited (SUNPHARMA) -44% Zoetis Inc (Z1TS34) -1% Hansoh Pharmaceutical Group (3692) -37% Divi's Laboratories Limited (DIVISLAB) -70%

Frequently asked questions

Is Jilin Province Xidian Pharmaceutical Sci-Tech Development Co (301130) undervalued?
As of Jun 24, 2026, our model estimates a fair value of ¥5.27 versus a price of ¥25.43 — about −79% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 301130?
Our 21-model fair value for Jilin Province Xidian Pharmaceutical Sci-Tech Development Co is ¥5.27 (as of Jun 24, 2026), built from audited fundamentals. The current price is ¥25.43.
What is the quality score of 301130?
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co has a Quality Score of 91/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.